Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02946021 · ClinicalTrials.gov registry record · Phase 1
Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema
A Phase 1 study, sponsored by Tactile Medical.
- Completed
- Registry status
- Phase 1
- Development phase
- 11
- Enrollment target
NCT02946021 is a Phase 1 study that has completed, run by Tactile Medical. The registered enrollment target is 11 participants.
The verdict
NCT02946021, a Phase 1 study, has completed, sponsored by Tactile Medical.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
Assessment of lymphatic structure and function pre- and post- treatment and during recovery in head and neck cancer related lymphedema patients using NIR fluorescence lymphatic imaging: Response to ICD therapy in HNC Patients.
Interventions
- DEVICE Head and neck garments for pneumatic compression device
- DRUG NIRFLI with ICG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2016-10 |
| Est. Completion | 2018-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02946021
The ClinicalTrials.gov registry entry for NCT02946021 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tactile Medical, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Head and neck garments for pneumatic compression device is the first listed.
NCT02946021 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02946021 about?
NCT02946021 is a clinical study titled "Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema". Assessment of lymphatic structure and function pre- and post- treatment and during recovery in head and neck cancer related lymphedema patients using NIR fluorescence lymphatic imaging: Response to ICD therapy in HNC Patients.
What is the current status of trial NCT02946021?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2016-10. Estimated completion is 2018-02.
What interventions are being tested in trial NCT02946021?
The interventions under investigation include: Head and neck garments for pneumatic compression device (DEVICE), NIRFLI with ICG (DRUG).
Who is sponsoring clinical trial NCT02946021?
This trial is sponsored by Tactile Medical, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.